Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer.
Acta Oncol
; 61(5): 619-624, 2022 05.
Article
in En
| MEDLINE
| ID: mdl-35139727
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
Type of study:
Health_economic_evaluation
Limits:
Female
/
Humans
Language:
En
Journal:
Acta Oncol
Journal subject:
NEOPLASIAS
Year:
2022
Document type:
Article
Affiliation country:
Netherlands
Country of publication:
United kingdom